vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and NETSTREIT Corp. (NTST). Click either name above to swap in a different company.
NETSTREIT Corp. is the larger business by last-quarter revenue ($57.1M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). NETSTREIT Corp. runs the higher net margin — 10.0% vs -4.8%, a 14.8% gap on every dollar of revenue. On growth, NETSTREIT Corp. posted the faster year-over-year revenue change (24.3% vs -47.3%). Over the past eight quarters, NETSTREIT Corp.'s revenue compounded faster (20.1% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
NETSTREIT Corp. is a US-headquartered real estate investment trust (REIT) that specializes in acquiring and operating a diversified portfolio of single-tenant net lease commercial properties. Its asset portfolio covers retail, industrial and office categories, primarily catering to investment-grade corporate tenants across the United States market.
IRWD vs NTST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $57.1M |
| Net Profit | $-2.3M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 34.1% |
| Net Margin | -4.8% | 10.0% |
| Revenue YoY | -47.3% | 24.3% |
| Net Profit YoY | -200.9% | 235.9% |
| EPS (diluted) | $0.01 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $57.1M | ||
| Q4 25 | $47.7M | $52.5M | ||
| Q3 25 | $122.1M | $48.3M | ||
| Q2 25 | $85.2M | $48.3M | ||
| Q1 25 | $41.1M | $45.9M | ||
| Q4 24 | $90.5M | $44.1M | ||
| Q3 24 | $91.6M | $41.4M | ||
| Q2 24 | $94.4M | $39.6M |
| Q1 26 | — | $5.7M | ||
| Q4 25 | $-2.3M | $1.3M | ||
| Q3 25 | $40.1M | $618.0K | ||
| Q2 25 | $23.6M | $3.3M | ||
| Q1 25 | $-37.4M | $1.7M | ||
| Q4 24 | $2.3M | $-5.4M | ||
| Q3 24 | $3.6M | $-5.3M | ||
| Q2 24 | $-860.0K | $-2.3M |
| Q1 26 | — | 34.1% | ||
| Q4 25 | 14.3% | 2.6% | ||
| Q3 25 | 61.8% | 1.3% | ||
| Q2 25 | 53.2% | 6.8% | ||
| Q1 25 | -70.7% | 3.7% | ||
| Q4 24 | 34.8% | -12.3% | ||
| Q3 24 | 28.0% | -12.8% | ||
| Q2 24 | 26.5% | -5.8% |
| Q1 26 | — | 10.0% | ||
| Q4 25 | -4.8% | 2.5% | ||
| Q3 25 | 32.8% | 1.3% | ||
| Q2 25 | 27.7% | 6.8% | ||
| Q1 25 | -90.9% | 3.7% | ||
| Q4 24 | 2.5% | -12.3% | ||
| Q3 24 | 4.0% | -12.8% | ||
| Q2 24 | -0.9% | -5.8% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.01 | $0.01 | ||
| Q3 25 | $0.23 | $0.01 | ||
| Q2 25 | $0.14 | $0.04 | ||
| Q1 25 | $-0.23 | $0.02 | ||
| Q4 24 | $0.03 | $-0.07 | ||
| Q3 24 | $0.02 | $-0.07 | ||
| Q2 24 | $-0.01 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $1.5B |
| Total Assets | $396.9M | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | — | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | $199.5M | $1.1B | ||
| Q2 25 | $199.3M | $926.6M | ||
| Q1 25 | $199.2M | $913.3M | ||
| Q4 24 | $199.0M | $868.3M | ||
| Q3 24 | $198.8M | $778.7M | ||
| Q2 24 | $198.6M | $726.2M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $-261.8M | $1.4B | ||
| Q3 25 | $-264.2M | $1.3B | ||
| Q2 25 | $-308.2M | $1.3B | ||
| Q1 25 | $-334.1M | $1.3B | ||
| Q4 24 | $-301.3M | $1.3B | ||
| Q3 24 | $-311.3M | $1.3B | ||
| Q2 24 | $-321.7M | $1.3B |
| Q1 26 | — | $2.8B | ||
| Q4 25 | $396.9M | $2.6B | ||
| Q3 25 | $396.1M | $2.5B | ||
| Q2 25 | $342.9M | $2.3B | ||
| Q1 25 | $327.2M | $2.3B | ||
| Q4 24 | $350.9M | $2.3B | ||
| Q3 24 | $389.5M | $2.2B | ||
| Q2 24 | $395.6M | $2.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.84× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | — |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $109.5M | ||
| Q3 25 | $47.6M | $28.0M | ||
| Q2 25 | $-15.1M | $30.6M | ||
| Q1 25 | $20.0M | $22.1M | ||
| Q4 24 | $15.2M | $90.2M | ||
| Q3 24 | $9.9M | $25.1M | ||
| Q2 24 | $33.5M | $25.4M |
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 82.46× | ||
| Q3 25 | 1.19× | 45.27× | ||
| Q2 25 | -0.64× | 9.36× | ||
| Q1 25 | — | 13.06× | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
NTST
| Rental revenue (including reimbursable) | $54.0M | 95% |
| Other | $3.0M | 5% |
